This audit is for higher specialty trainees, usually ST4 and above, using BMJ OnExamination for the SCE in Neurology. Unlike medical oncology, BMJ does publish a neurology bank, so the question is not whether it covers the exam but what its adaptive engine is actually optimising, and why the number on the home screen is not a readiness signal. The principal limitation is that the engine optimises engagement and weak-area exposure, not blueprint balance, so you must impose the blueprint yourself.
What BMJ OnExamination offers for SCE Neurology right now
Figures below are vendor-reported and were checked on 20 July 2026.
| Item | Finding (vendor-reported, 20 July 2026) |
|---|---|
| Question count | 230+ questions covering the neurology curriculum. |
| Price | Tiered by access length, from £69.99 for one month to £189.99 for twelve months. |
| Free access | Ten free questions per day without subscription. |
| Analytics engine | "High Impact Questions" ranking by clinician and peer input; filters by topic, type, difficulty and keyword; performance graphs benchmarked against peers; a vendor pass-likelihood indicator; timed mock tests; a daily personalised question; leaderboard-style group play. |
| Adaptive claim | Difficulty selection and prioritised feed, not a published adaptive-difficulty algorithm; treat the ranking as popularity and weakness weighting, not a proprietary engine. |
The strengths are a polished analytics dashboard, a large user base for peer benchmarking, and a genuine mock mode. The limitation for neurology specifically is volume: 230-plus items is a reasonable supplementary set but is finite, and the adaptive feed will circle your weak topics rather than hold the exam's blueprint proportions.
The exam you are preparing for: the SCE Neurology blueprint
The SCE in Neurology is two papers of 100 best-of-five questions, 200 in total, three hours per paper, one day, computer-based on Surpass, one mark per correct answer, no negative marking. Only the blueprint is specialty-specific.
| Blueprint domain | Indicative questions (of 200) |
|---|---|
| Disorders of consciousness and epilepsy | 20 |
| Neurogenetics, neuroendocrinology, neurotoxicology, neuro-urology, neuro-otology | 20 |
| Neuro-inflammatory disorders | 20 |
| Cerebrovascular disease | 15 |
| Disorders of the peripheral nervous system and muscle | 15 |
| Neurological disorders in special groups | 15 |
| Neurophysiology, neuroradiology, neuropathology | 15 |
| Neurorehabilitation, neuropsychology and neuropsychiatry | 15 |
| Neurosurgery and intensive care | 15 |
| Pain and headache | 15 |
| Parkinsonism and movement disorders | 15 |
| Disorders of the cranial nerves and visual system | 10 |
| Disorders of the spinal cord and motor neurone disease | 10 |
| Total | 200 |
Verify the current blueprint on thefederation.uk. Note that no single domain dominates: epilepsy, neuro-inflammatory disease and the neurogenetics-and-systems cluster each carry the most marks, so a candidate who over-drills stroke and headache while neglecting neurophysiology and neurogenetics is misaligned with the exam.
The analytics vocabulary: what every metric means
Define the dashboard's numbers before trusting them. First-attempt accuracy is your percentage on never-seen items and is the only figure that behaves like the exam. Repeat accuracy is inflated by memory of the answer. Percentile benchmarks you against BMJ users, not the SCE cohort. The pass-likelihood indicator, which the vendor frames as showing "how likely you are to pass", is a heuristic, not a validated prediction, and must not be read as a probability of passing. Coverage is the share of a domain you have attempted. Difficulty is the cohort's failure rate on an item. Time per item is your mean seconds against a budget near 108 seconds. The gap between first-attempt and repeat accuracy is your most honest number.
What the adaptive engine is actually optimising
A weakness-weighted, popularity-ranked feed optimises two things: keeping you engaged with material you find hard, and surfacing items other users rate highly. Neither is the same as holding the exam blueprint. As the feed concentrates on your weakest neurology topics, your rolling percentage drops even as you improve, because the denominator fills with your hardest items. Conversely, re-testing mastered movement-disorder items inflates the percentage through sampling. This is why a raw bank percentage is not comparable with a mixed, unseen mock, and why Your Q-Bank Percentage Is Not Your Exam Score is the caveat to hold in mind.
Auditing your attempted-question distribution against the blueprint
Do not trust the home-screen average. Record your attempted count per domain and lay it beside the blueprint. The audit question is whether you have attempted enough unseen items in each domain, weighted as the exam weights them. A candidate with 120 stroke and headache items but 15 neurophysiology and 10 neurogenetics items has a coverage hole where the marks are dense. Completion of a 230-item bank is not coverage of a 200-mark blueprint; build the matrix deliberately.
The readiness test: five conditions for a signal you can trust
The number is a readiness signal only when all five hold: items unseen, block timed at exam pace, content mixed and blueprint-proportional, sat with no assistance, and a sample of at least 80 to 100 items. Fail one condition and the number is feedback, not a readiness estimate. With only 230-plus items in the bank, meeting the unseen condition repeatedly is itself a challenge, which is the core reason to add a second source for measurement late in revision.
Override rules: what to force into your feed
Adaptive and popularity feeds under-surface low-volume, high-consequence neurology material. Force the following even if the engine never prioritises them: localisation and neuroanatomy items where the lesion site is the answer; neurophysiology, EEG and nerve-conduction or EMG interpretation; neuroimaging pattern recognition; syndrome discrimination, such as Parkinson-plus syndromes versus idiopathic Parkinson's, and the multiple sclerosis, NMOSD and MOGAD distinction; neurogenetics; and any image or data-interpretation item. Because disease-modifying therapy in neuro-inflammatory disease and anti-seizure medication choice change over time, verify drug specifics against the SmPC on the eMC and current NICE and SIGN guidance rather than a static explanation.
Worked dashboard example: from analytics to next week's quotas
Suppose a candidate shows overall first-attempt accuracy of 68%, but 55% on neuro-inflammatory disorders, 60% on movement disorders, 52% on neurophysiology and neuroradiology, and 80% on headache, with only 30% coverage of neurophysiology and a mean of 92 seconds per item. Read against the blueprint, two of the three weakest domains carry high weight and coverage is thinnest exactly there.
Next week's quotas follow without any pass prediction. Allocate 45 unseen items to neuro-inflammatory disorders, 35 to neurophysiology and neuroradiology to close the coverage gap, 30 to movement disorders, a maintenance 15 to headache, and 20 forced localisation or imaging items. Hold pace at 100 to 108 seconds. Re-measure on a fresh unseen block and compare first-attempt to first-attempt.
A seven-day pattern for trainees revising around clinical work
This loop uses BMJ OnExamination for one defined job, drilling weak neurology domains with its analytics, and iatroX as the unseen transfer-measurement layer. It makes no claim about any internal algorithm.
- Day 1: 40 BMJ items in your weakest domain; log misses by mechanism, not topic.
- Day 2: Read around Day 1 misses using primary sources, the SmPC and NICE or SIGN; no new questions.
- Day 3: 40 BMJ items in the second weakest domain.
- Day 4: Re-test Day 1 misses; add 20 forced localisation, EEG or imaging items.
- Day 5: Read around Day 3 and Day 4 misses.
- Day 6: Timed, mixed, blueprint-proportional 80 to 100 item block. Because a 230-item bank quickly runs short of unseen items, sit a fresh timed unseen block in iatroX to test whether the knowledge transfers to items you have never seen.
- Day 7: Light review; set next week's quotas from the Day 6 unseen result.
Three mistakes this audit is designed to stop
The first is reading a falling percentage as falling readiness when the adaptive feed has simply concentrated your hardest items. The second is trusting the pass-likelihood indicator as a calibrated probability; it is a convenience, not an examiner's judgement. The third is letting the engine set your blueprint, so you over-revise headache and stroke and under-revise neurophysiology, neurogenetics and neuro-inflammatory disease, which is where the marks concentrate.
Decision checklist: continue, supplement, switch or stop
| Situation (measurable) | Action |
|---|---|
| Early revision, bank barely started | Continue; use BMJ for weak-area drilling. |
| First-attempt accuracy rising, coverage even | Continue; do not add tools for novelty. |
| One or two high-weight domains persistently low | Supplement with forced quotas and reading, not a new bank. |
| Bank running short of unseen items, repeats dominating | Add a second, unseen source; apply the two-Q-bank rule. |
| Unseen, timed, mixed first-attempt consistently comfortable | Stop adding volume; move to timed mixed mocks and rest. |
Bottom line
BMJ OnExamination is a capable adaptive platform with a genuine SCE Neurology bank, and its analytics are worth using, provided you understand that the engine optimises weak-area exposure and engagement, not blueprint balance. Impose the 200-mark blueprint yourself, force the low-volume high-consequence topics, and measure readiness on unseen, timed, blueprint-proportional blocks rather than on a rolling percentage. With only 230-plus items, plan for a second unseen source late on.
Frequently asked questions
Is BMJ OnExamination enough for SCE Neurology on its own? It is a reasonable supplementary bank rather than a sufficient sole resource, because its 230-plus items, while genuinely mapped to the neurology curriculum, are finite and its adaptive feed does not hold the blueprint proportions. Most candidates should combine it with a larger specialist neurology bank for volume and with an unseen source for measurement, and should verify fast-moving therapy facts against primary sources.
Which SCE Neurology component does BMJ OnExamination not reproduce well? The components least well served by any best-of-five bank are localisation reasoning, neurophysiology such as EEG and nerve-conduction interpretation, neuroimaging pattern recognition and fine syndrome discrimination, because these are visual, sequential and hard to compress into a single stem. BMJ's mock mode helps with pacing but cannot fully rehearse image-dense interpretation, so force those items and read around them.
How many BMJ OnExamination questions should I complete per day for SCE Neurology? A sustainable target for a trainee working clinically is roughly 30 to 50 unseen items per revision day, logged by mechanism, with reading days interleaved. Because the bank is finite, resist burning through it in long unbroken sessions; spacing the misses and analysing them well matters more than daily volume.
When should I stop using BMJ OnExamination and move to mixed mocks? Move once your first-attempt accuracy is stable and even across the high-weight domains and once the bank is running short of genuinely unseen items. At that point the adaptive feed has given what it can, and timed, blueprint-proportional mixed mocks are the better rehearsal for pacing and decision-switching in the final weeks.
How should I combine BMJ OnExamination with iatroX without duplicating practice? Assign each tool one job: use BMJ to drill and analyse weak neurology domains with its dashboard, and use iatroX only as the unseen measurement layer on fresh, timed blocks you have never attempted. That keeps the second tool measuring transfer rather than re-testing BMJ's items, and lets you compare first-attempt accuracy across the two sources honestly.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 20 July 2026. Platform figures, including question counts, prices and features, are vendor-reported and change without notice; confirm current details on the product pages before relying on them. Disclosure: iatroX operates a UK question bank and clinical-knowledge platform and therefore competes with the products discussed; iatroX does not publish a specialty-specific SCE Neurology bank, and its role here is confined to cross-specialty knowledge and unseen-MCQ measurement, a job the audited product does not claim. Corrections are welcome via the feedback route on iatrox.com.
References: Federation of Royal Colleges of Physicians of the UK, SCE in Neurology and blueprint (thefederation.uk); BMJ OnExamination SCE in Neurology and features pages (onexamination.com); iatroX, Your Q-Bank Percentage Is Not Your Exam Score; iatroX comparison hub.
Run a fresh, timed unseen block in iatroX and decide your next move →